Patents by Inventor Manlio Blandamura

Manlio Blandamura has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Therapeutic use of cyproterone acetate
    Patent number: 4639440
    Abstract: There is disclosed a new therapeutic use of cyproterone acetate, to block the estrogen signal in the treatment of functional and tumoral estrogen-dependant pathology, in women, caused by intrafollicular iperestrogenism in a pharmaceutically-acceptable dosage.
    Type: Grant
    Filed: September 24, 1985
    Date of Patent: January 27, 1987
    Assignee: Finchimica S.R.L.
    Inventor: Manlio Blandamura
  • Pharmacological use of cyproterone acetate
    Patent number: 4344942
    Abstract: The 6-chloro-1,2.alpha.-methylene-4,6-pregnadien-17.alpha.-ol-3,20-dione-17-ac etate (Cyproterone acetate) is a well known compound provided with a remarkably high anti-androgen activity. It has now surprisingly been found that the Cyproterone acetate shows an equally high anti-estrogen activity in menopause or pre-menopause women and can be used for treating women having cystic glandular hyperplasia of the endometrium.
    Type: Grant
    Filed: July 1, 1981
    Date of Patent: August 17, 1982
    Assignee: Finchimica S.R.L.
    Inventor: Manlio Blandamura